SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-047683
Filing Date
2023-10-11
Accepted
2023-10-11 08:15:16
Documents
14
Period of Report
2023-10-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20012277x2_8k.htm   iXBRL 8-K 53273
2 EXHIBIT 99.1 ny20012277x2_ex99-1.htm EX-99.1 15004
6 ny20012277x2_ex99-1img01.jpg GRAPHIC 7868
  Complete submission text file 0001140361-23-047683.txt   228766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hrmy-20231010.xsd EX-101.SCH 3895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrmy-20231010_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrmy-20231010_pre.xml EX-101.PRE 16064
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20012277x2_8k_htm.xml XML 4253
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 231319455
SIC: 2834 Pharmaceutical Preparations